Insulin-like growth factor-1 boosts the developing process of condylar hyperplasia by stimulating chondrocytes proliferation

Osteoarthritis and Cartilage

Volumn 20, Issue 4, 2012, Pages 279-287

  Chen, Y ^a,b   Ke, J ^a,b   Long, X ^b   Meng, Q ^b   Deng, M ^b   Fang, W ^b   Li, J ^b   Cai, H ^b   Chen, S ^b  

^a WUHAN UNIVERSITY   (China)

^b Wuhan University   (China)

Author keywords

Cellular proliferation; Chondrocyte; Condylar hyperplasia(CH); Insulin like growth factor 1(IGF 1); Temporomandibular joint (TMJ)

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ALGINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NVP AEW 541; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; CARTILAGE CELL; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONDYLAR HYPERPLASIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPERPLASIA; MALE; MOLECULAR MECHANICS; MONOLAYER CULTURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; EXTRACELLULAR MATRIX; FEMALE; HUMANS; HYPERPLASIA; INSULIN-LIKE GROWTH FACTOR I; MALE; MANDIBULAR CONDYLE; MAP KINASE SIGNALING SYSTEM; MICROSCOPY, PHASE-CONTRAST; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; TEMPOROMANDIBULAR JOINT; YOUNG ADULT;

EID: 84862826132     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.12.013     Document Type: Article

References (38)

1. Feldmann G., Linder-Aronson S., Rindler A., Soderstrom U. Orthodontic and surgical treatment of unilateral condylar hyperplasia during growth - a case report. Eur J Orthod 1991, 13:143-148.
2. Eslami B., Behnia H., Javadi H., Khiabani K.S., Saffar A.S. Histopathologic comparison of normal and hyperplastic condyles. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 96:711-717.
3. Wolford L.M., Mehra P., Reiche-Fischel O., Morales-Ryan C.A., Garcia-Morales P. Efficacy of high condylectomy for management of condylar hyperplasia. Am J Orthod Dentofacial Orthop 2002, 121:136-150. discussion 50-1.
4. Lippold C., Kruse-Losler B., Danesh G., Joos U., Meyer U. Treatment of hemimandibular hyperplasia: the biological basis of condylectomy. Br J Oral Maxillofac Surg 2007, 45:353-360.
5. Gray R.J., Sloan P., Quayle A.A., Carter D.H. Histopathological and scintigraphic features of condylar hyperplasia. Int J Oral Maxillofac Surg 1990, 19:65-71.
6. Maki R.G. Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol 2010, 28:4985-4995.
7. Wu S., Fadoju D., Rezvani G., De Luca F. Stimulatory effects of insulin-like growth factor-I on growth plate chondrogenesis are mediated by nuclear factor-kappaB p65. J Biol Chem 2008, 283:34037-34044.
8. Brodt P., Samani A., Navab R. Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy. Biochem Pharmacol 2000, 60:1101-1107.
9. Harrington E.A., Bennett M.R., Fanidi A., Evan G.I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 1994, 13:3286-3295.
10. Shen G., Darendeliler M.A. The adaptive remodeling of condylar cartilage - a transition from chondrogenesis to osteogenesis. J Dent Res 2005, 84:691-699.
11. Gotz W., Lehmann T.S., Appel T.R., Rath-Deschner B., Dettmeyer R., Luder H.U., et al. Distribution of insulin-like growth factors in condylar hyperplasia. Ann Anat 2007, 189:347-349.
12. Meng Q., Long X., Deng M., Cai H., Li J. The expressions of IGF-1, BMP-2 and TGF-beta1 in cartilage of condylar hyperplasia. J Oral Rehabil 2011, 38:34-40.
13. Hodder S.C., Rees J.I., Oliver T.B., Facey P.E., Sugar A.W. SPECT bone scintigraphy in the diagnosis and management of mandibular condylar hyperplasia. Br J Oral Maxillofac Surg 2000, 38:87-93.
14. Gomez-Camarillo M.A., Almonte-Becerril M., Vasquez Tort M., Tapia-Ramirez J., Kouri Flores J.B. Chondrocyte proliferation in a new culture system. Cell Prolif 2009, 42:207-218.
15. De Ceuninck F., Lesur C., Pastoureau P., Caliez A., Sabatini M. Culture of chondrocytes in alginate beads. Methods Mol Med 2004, 100:15-22.
16. Shi S., Mercer S., Eckert G.J., Trippel S.B. Growth factor regulation of growth factors in articular chondrocytes. J Biol Chem 2009, 284:6697-6704.
17. Kiepe D., Ciarmatori S., Hoeflich A., Wolf E., Tonshoff B. Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways. Endocrinology 2005, 146:3096-3104.
18. Yin W., Park J.I., Loeser R.F. Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways. J Biol Chem 2009, 284:31972-31981.
19. Diekman B.O., Estes B.T., Guilak F. The effects of BMP6 overexpression on adipose stem cell chondrogenesis: Interactions with dexamethasone and exogenous growth factors. J Biomed Mater Res A 2010, 93:994-1003.
20. Halawani D., Mondeh R., Stanton L.A., Beier F. p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation. Oncogene 2004, 23:3726-3731.
21. Ke J., Long X., Liu Y., Zhang Y.F., Li J., Fang W., et al. Role of NF-kappaB in TNF-alpha-induced COX-2 expression in synovial fibroblasts from human TMJ. J Dent Res 2007, 86:363-367.
22. Finger F., Schorle C., Zien A., Gebhard P., Goldring M.B., Aigner T. Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2. Arthritis Rheum 2003, 48:3395-3403.
23. Farina R.A., Becar M., Plaza C., Espinoza I., Franco M.E. Correlation between single photon emission computed tomography, AgNOR count, and histomorphologic features in patients with active mandibular condylar hyperplasia. J Oral Maxillofac Surg 2011, 69:356-361.
24. Grey A., Chen Q., Xu X., Callon K., Cornish J. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Endocrinology 2003, 144:4886-4893.
25. Molhoek K.R., Shada A.L., Smolkin M., Chowbina S., Papin J., Brautigan D.L., et al. Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R. Melanoma Res 2011.
26. Ucar D.A., Kurenova E., Garrett T.J., Cance W.G., Nyberg C., Cox A., et al. Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. Carcinogenesis 2011.
27. Luo D.X., Peng X.H., Xiong Y., Liao D.F., Cao D., Li L. Dual role of insulin-like growth factor-1 in acetyl-CoA carboxylase-alpha activity in human colon cancer cells HCT-8: downregulating its expression and phosphorylation. Mol Cell Biochem 2011.
28. Davison Z., de Blacquiere G.E., Westley B.R., May F.E. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy. Neoplasia 2011, 13:504-515.
29. Caliari S.R., Harley B.A. The effect of anisotropic collagen-GAG scaffolds and growth factor supplementation on tendon cell recruitment, alignment, and metabolic activity. Biomaterials 2011, 32:5330-5340.
30. Enlow D.H., Pfister C., Richardson E., Kuroda T. An analysis of Black and Caucasian craniofacial patterns. Angle Orthod 1982, 52:279-287.
31. Luder H.U., Leblond C.P., von der Mark K. Cellular stages in cartilage formation as revealed by morphometry, radioautography and type II collagen immunostaining of the mandibular condyle from weanling rats. Am J Anat 1988, 182:197-214.
32. Acharya C., Adesida A., Zajac P., Mumme M., Riesle J., Martin I., et al. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol 2012, 227:88-97.
33. Hopkins A., Crowe P.J., Yang J.L. Effect of type 1 insulin-like growth factor receptor targeted therapy on chemotherapy in human cancer and the mechanisms involved. J Cancer Res Clin Oncol 2010, 136:639-650.
34. Feng Z., Levine A.J. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol 2010, 20:427-434.
35. Petley T., Graff K., Jiang W., Yang H., Florini J. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 1999, 31:70-76.
36. Nishimoto S., Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 2006, 7:782-786.
37. Wang X., Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal 2006, 18:753-760.
38. Shi S., Gronthos S., Chen S., Reddi A., Counter C.M., Robey P.G., et al. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol 2002, 20:587-591.